1. Home
  2. CANF vs HIHO Comparison

CANF vs HIHO Comparison

Compare CANF & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.32

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

HOLD

Current Price

$0.81

Market Cap

4.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANF
HIHO
Founded
1994
1990
Country
Israel
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
4.2M
IPO Year
2011
2002

Fundamental Metrics

Financial Performance
Metric
CANF
HIHO
Price
$3.32
$0.81
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$9,750.00
N/A
AVG Volume (30 Days)
609.7K
80.7K
Earning Date
03-27-2026
03-02-2026
Dividend Yield
N/A
14.62%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$461.72
N/A
Revenue Next Year
$290,391.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.77
52 Week High
$10.40
$2.21

Technical Indicators

Market Signals
Indicator
CANF
HIHO
Relative Strength Index (RSI) 35.57 35.96
Support Level $0.60 $0.77
Resistance Level $4.74 $1.04
Average True Range (ATR) 0.64 0.07
MACD -0.17 0.00
Stochastic Oscillator 0.54 6.42

Price Performance

Historical Comparison
CANF
HIHO

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

Share on Social Networks: